As a leading custom service provider, Creative Biolabs has devoted to the development of T cell therapy for many years, such as T cell receptor (TCR) gene therapy. By altering the specificity of T cell receptor (TCR), we can genetically modify T cells to enhance their tumor-killing activity, which is an attractive approach. Creative Biolabs offers product and services for TCR-modified T cells.
TCR is a molecule expressed on T lymphocyte surface that mediates antigen-specific recognition and reactivity through presenting antigenic peptides to the MHC. TCR heterodimers consist of α and β chains or γ and δ chains. Introducing genes encoding a tumor-reactive TCR could be used to generate T cells toward an antigen of interest, thereby establishing tumor antigen-specific T cells which are used to infuse to the patient. In order to alter T-cell specificity, genetically modified TCR therapies are developed. They are achieved by the expression of specific TCR α and β chains to mediate the antigen-recognition process. One powerful approach to examine T-cell receptor (TCR) properties and T-cell function is to clone TCR genes into retroviral vectors and use them to transfer antigen specificity into other cells. One drawback of this approach is that the cloning of the TCR genes into the retroviral vector is a somewhat complicated, time-consuming process.
Based on the general method of TCR construction, Creative Biolabs optimizes the strategies that we combine the conventional steps into a single process, expediting TCR vector production. This one step approach greatly streamlines the TCR vector production process versus the traditional three-step process that typically involves cloning whole TCR genes, producing a TCR expression cassette, and constructing a retroviral construct. More than that, we can tailor the design and construction of TCR products for our clients to meet your special needs. γδ TCR-T development service is also available from us.
Creative Biolabs has the capability to enable you to free up your time for core work and project. Our service can be designed to meet your special needs if you have any requirements. If you are interested in our service, please contact us by E-mail and our team will get back to you as soon as possible.
For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy product with the complete TCR complex without HLA matching dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE